The audience learned from Dirk Colaert about the research challenges that remain in advancing the capability of health ICT solutions to support coordinated and integrated care, centring on the patient and optimising both healthcare and research processes. Many of these topics are expected to be part of future calls for research proposals under Horizon 2020. Tomas Andersson presented the vision of a strong partnership between the pharma industry and hospitals towards jointly identifying the knowledge needed to improve clinical outcomes and accelerate healthcare innovation. Katie Gallagher emphasised the many important roles that empowered patients can play in self-managing their health conditions, prevention and playing a greater part in clinical research. The European Patients’ Forum is working alongside many national patient associations and the European Commission to promote and support the active participation of patients in health decision-making and in research. Jacques Demotes emphasised that high-quality clinical research is achievable through the involvement of well-trained staff, efficient and well-organised research facilities, and strong coordination among trial centres—particularly in the expanding landscape of multinational clinical trials. ECRIN plays a vital role in developing the standards for this and accrediting clinical trial centres to these standards. The audience learned from Pascal Garel that hospitals all over Europe need to innovate in order to take advantage of the very real benefits offered through health ICT, robotics and machine learning technologies, and to deliver more personalised medicine. This includes providing more integrated care and centring care more strongly on the patient including shared decision-making.
Turning the spotlight on specific hospitals that have already achieved significant advances in integrating and reusing their data for research and quality improvement, the audience learned from Philippe Lechat of the Assistance Publique - Hôpitaux de Paris, Tony Amato from the Policlinico Gemelli in Rome and Giuseppe Banfi from the Fondazione Centro San Raffaele in Milan about how they have established a culture and governance around combining data from multiple local hospitals and developed clinical data warehouses that can be analysed securely using advanced electronic health record systems and clinical research workflow systems. The speakers described how these systems have made the conduct and monitoring of clinical research more efficient and enabled accelerated knowledge discovery and the translation of that knowledge into improved healthcare. John O’Brien explained how good quality data is now vital for hospitals to deliver a high-quality and efficient service, to focus their services on patients and to recruit and retain excellent staff. Health information and EHR systems are a critical part of hospital operation: a factor of production. However, it is essential that these systems are quality-assured and that the information workforce is suitably trained and credentialed.
i~HD is developing good practices and support resources to help accelerate the capability of hospitals and other stakeholders to make maximum use of health data. Pascal Coorevits described the newly launched i~HD Quality Seal for Clinical Research Platforms (QS4RP) that has been jointly developed with EuroRec and is now starting to be applied to assess platform service providers and their products. Nathan Lea described the importance of trust and trustworthiness, especially from patients, in the reuse of EHRs for research and outlined the instruments that i~HD has developed to support good and trustworthy practice. Carlos Sáez explained the importance of good quality data to making correct decisions about healthcare and making valid inferences for research, and the work of the i~HD Data Quality Task Force in developing assessment methods and improvement strategies.